文献速递药物不良反应与药物警戒

药物警戒生态系统的演变:摩尔定律是否提示应用奥卡姆剃刀?

The evolution of pharmacovigilance ecosystems: Does Moore's law invite the use of Occam's razor?
PubMed 文献 · Br J Clin Pharmacol · 2022-11-12

本文探讨药物警戒系统复杂性增加的驱动因素,聚焦监管环境、数据管理与评估。研究指出,创新方法(如药物基因组学和被动传感器)将导致数据量和病例报告量增加,且法规指南繁多而缺乏协调。结论提出,在复杂多变的环境中应回归简洁与实用,应用奥卡姆剃刀原则有助于支持新药快速可及且获益风险比良好。

要点

  • 药物警戒系统复杂性受监管环境、数据管理与评估驱动而持续增加。
  • 药物基因组学与被动传感器等创新方法将增加数据量和病例报告量。
  • 法规指南繁多且缺乏协调,需回归简洁与实用原则。

核心结论

  • 在复杂且快速变化的药物警戒环境中,需要回归简洁与实用。
  • 应用奥卡姆剃刀原则可帮助支持新药快速可及且获益风险比良好。

研究设计与样本

  • 本文为对药物警戒系统复杂性驱动因素的探索性分析,聚焦监管环境、数据管理与评估。

主要发现

  • 上市后数据评估在药物警戒中作用日益重要,各方利益相关者均关注优化利用这些数据。
  • 创新方法包括药物基因组学和被动措施(传感器),将导致复杂性和数据量增加,并不可避免地增加病例报告量。
  • 管理这些数据的法规和指南繁多,存在固有的缺乏协调问题。

临床怎么用

  • 在药物警戒实践中应关注上市后数据的优化利用。
  • 面对法规指南缺乏协调的现状,可考虑以简洁实用为原则整合安全数据管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Moore's law predicts the doubling of complexity of integrated circuits every 2 years; Kryder's corollary assumes a doubling of data storage every 13 months. With the increasing volume of legislation, pharmacovigilance systems today are inherently complex, and the emphasis has shifted from reactive (responding to emerging risks) to planned, active, risk-proportionate approaches operating throughout the life cycle of medicines. METHODS: Exploration of the drivers for increasing complexity of pharmacovigilance systems, focusing on regulatory environment, data management and evaluation. RESULTS: Evaluation of postmarketing data plays an increasingly important role in pharmacovigilance. There is great interest on the part of all stakeholders in optimizing the use of these data. Innovative approaches, including pharmacogenetics and passive measures (sensors), will lead to increased complexity and volumes of data and inevitably to an increase in the volume of case reports. There is a multiplicity of regulations and guidelines on how to manage these data, with an inherent lack of harmonization. CONCLUSION: We summarize the current characterization of safety data types, sources and the classification of these data. Using this benchmark, we discuss the future requirements of an effective pharmacovigilance ecosystem, keeping the principle of parsimony in mind. In this complex, continuously and rapidly changing environment, there is a need for a return to simplicity and pragmatism. The application of Occam's razor could help to support the rapid provision of new, affordable medicines with a positive benefit to risk profile.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Mueller M, Lewis DJ, Alexe A, et al. The evolution of pharmacovigilance ecosystems: Does Moore's law invite the use of Occam's razor? Br J Clin Pharmacol. 2022. PMID: 36264908. doi:10.1111/bcp.15573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。